[{"address1": "960 San Antonio Road", "city": "Palo Alto", "state": "CA", "zip": "94303", "country": "United States", "phone": "650 516 4310", "website": "https://www.scilexholding.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company also develops three product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel - SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4%, a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules), a novel low-dose delayed-release naltrexone hydrochloride, which has completed phase 1 trials for the treatment of fibromyalgia. It has an agreement with Oishi and Itochu to develop lidocaine tape products, including ZTlido and SP-103; and Lifecore Biomedical, LLC for clinical trial material manufacturing and development services for SEMDEXA. Scilex Holding Company is headquartered in Palo Alto, California.", "fullTimeEmployees": 31, "companyOfficers": [], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.14, "open": 17.32, "dayLow": 17.32, "dayHigh": 20.26, "regularMarketPreviousClose": 17.14, "regularMarketOpen": 17.32, "regularMarketDayLow": 17.32, "regularMarketDayHigh": 20.26, "payoutRatio": 0.0, "beta": 1.334, "forwardPE": -48.38462, "volume": 463876, "regularMarketVolume": 463876, "averageVolume": 202496, "averageVolume10days": 360950, "averageDailyVolume10Day": 360950, "bid": 18.55, "ask": 19.06, "bidSize": 1, "askSize": 1, "marketCap": 131254064, "fiftyTwoWeekLow": 3.6, "fiftyTwoWeekHigh": 43.05, "priceToSalesTrailing12Months": 2.9671323, "fiftyDayAverage": 10.6, "twoHundredDayAverage": 12.214825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 149003584, "profitMargins": -1.79121, "floatShares": 2918258, "sharesOutstanding": 6955700, "sharesShort": 447389, "sharesShortPriorMonth": 439198, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0792, "heldPercentInsiders": 0.21576999, "heldPercentInstitutions": 0.09127, "shortRatio": 2.05, "shortPercentOfFloat": 0.108, "impliedSharesOutstanding": 6955700, "bookValue": -45.292, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -122989000, "trailingEps": -15.54, "forwardEps": -0.39, "lastSplitFactor": "1:35", "lastSplitDate": 1744675200, "enterpriseToRevenue": 3.368, "enterpriseToEbitda": -1.567, "52WeekChange": -0.52706766, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 18.87, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 4099000, "totalCashPerShare": 0.746, "ebitda": -95083000, "totalDebt": 49365000, "quickRatio": 0.068, "currentRatio": 0.11, "totalRevenue": 44236000, "revenuePerShare": 5.869, "returnOnAssets": -0.65790004, "grossProfits": 31121000, "freeCashflow": 48161376, "operatingCashflow": 20704000, "revenueGrowth": -0.395, "grossMargins": 0.70352, "ebitdaMargins": -2.14945, "operatingMargins": -2.06265, "financialCurrency": "USD", "symbol": "SCLX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Scilex Holding Company", "longName": "Scilex Holding Company", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1614954600000, "postMarketChangePercent": 0.10598066, "postMarketPrice": 18.89, "postMarketChange": 0.01999855, "regularMarketChange": 1.73, "regularMarketDayRange": "17.32 - 20.26", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755906925, "regularMarketTime": 1755892800, "exchange": "NCM", "messageBoardId": "finmb_607715156", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 10.0934, "regularMarketPrice": 18.87, "cryptoTradeable": false, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 202496, "fiftyTwoWeekLowChange": 15.27, "fiftyTwoWeekLowChangePercent": 4.241667, "fiftyTwoWeekRange": "3.6 - 43.05", "fiftyTwoWeekHighChange": -24.179998, "fiftyTwoWeekHighChangePercent": -0.56167245, "fiftyTwoWeekChangePercent": -52.706764, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -15.54, "epsForward": -0.39, "epsCurrentYear": -3.51, "priceEpsCurrentYear": -5.3760686, "fiftyDayAverageChange": 8.27, "fiftyDayAverageChangePercent": 0.7801887, "twoHundredDayAverageChange": 6.655176, "twoHundredDayAverageChangePercent": 0.5448442, "priceToBook": -0.41662988, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "displayName": "Scilex Holding", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]